Dr Ariane Lewis discusses how we can navigate uncertainty and ambiguity about brain death by understanding clinical criteria for brain death determination and how our approaches to death are culturally and socially situated.
The opioid crisis, maternal death, and COVID-19 underscore trust as foundational to public health and call for redefinition of what it means to be a US clinician.
AMA J Ethics. 2021;23(3):E265-270. doi:
10.1001/amajethics.2021.265.
This article considers force use in clinical settings after a triggering event—a behavioral or medical crisis—and considers how it should be implemented.
AMA J Ethics. 2021;23(4):E326-334. doi:
10.1001/amajethics.2021.326.
This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing.
AMA J Ethics. 2021;23(6):E471-479. doi:
10.1001/amajethics.2021.471.
Drs Arya Shah, Carmen Black Parker, and Ambrose H. Wong join us on this episode of Ethics Talk to discuss force, the role of authority, and how clinicians should not just minimize harm but demonstrate compassion.
Dr Travis Rieder discusses his own experiences with opioids and the ethical challenges of “legacy patients,” and Dr Stephanie Zaza, president of the American College of Preventive Medicine, discusses the future of opioid research priorities.